By Ralph Morgan Cannabis Industry leaders and activists are seemingly the only two groups with a sense of urgency to find a reasonable alternative pain remedy to replace synthetic opioids. Pharmaceuticals are responsible for a death every 19 minutes. Big Pharma, in order to preserve pride and profit, is funding opposition to deter cannabis legalization […]
Insys
FDA Approves Insys Therapeutics’ 2nd Cannabis-Based Drug
On June 21, Todd Hagopian recommended Insys Therapeutics (INSY). Since then, the stock has gained nearly 20%. After a stock runs like this, many investors are tempted to sell. However, in situations like this, I’ve found it valuable to know which side of the trade the people with superior track records are on before making any trading […]
